Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Fuji
Cipla
Harvard Business School
Daiichi Sankyo
Julphar
Chubb
Queensland Health
McKesson
Federal Trade Commission

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,211,938

« Back to Dashboard

Summary for Patent: 5,211,938
Title: Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors
Abstract:A method of detecting and treating malignant and nonmalignant tissue abnormalities and lesions of the skin, conjunctives, respiratory, digestive and vaginal mucosa; endometrium and urothelium in which 5-aminolevulinic acid is administered to the patient in an amount sufficient to induce synthesis of protoporphyrin IX in the lesions, followed by exposure of the treated lesion to a photoactivating light in the range 350-640 nm.
Inventor(s): Kennedy; James C. (Kingston, CA), Pottier; Roy H. (Kingston, CA), Reid; Robert L. (Kingston, CA)
Assignee: Queen's University at Kingston (Kingston, CA)
Application Number:07/783,750
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,211,938

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,211,938

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0831909 ➤ Sign Up
Australia 624985 ➤ Sign Up
Australia 674310 ➤ Sign Up
Australia 3883293 ➤ Sign Up
Australia 5888796 ➤ Sign Up
Australia 6034390 ➤ Sign Up
Canada 2126761 ➤ Sign Up
Canada 2133741 ➤ Sign Up
Canada 2223522 ➤ Sign Up
Canada 2461070 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Deloitte
AstraZeneca
US Department of Justice
McKesson
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot